1. C.L. Litterst, T.E. Gram, R.L. Dedrick, A.F. LeRoy andA.M. Guarino,Distribution and disposition of platinum following intravenous administration of cisdichlorodiammineplatinum (II) to dogs, Cancer Res.36, 2340–2344 (1976).
2. R.G. Pretorius, E.S. Petrilli, C. Kean, L.C. Ford, J. D. Hoeschele andK.D. Lagasse,Comparison of IV and IP routes of administration of cisplatin in dogs, Cancer Treat. Reports65, 1055–1062 (1981).
3. J.J. Gullo, C.L. Litterst, P.J. McGuire, B.I. Sikic, D.F. Hoth andP.V. Wooley,Pharmacokinetics and protein binding of cisdichlorodiammineplatinum (II) adminstered as a 1 hour or as a 20 hour infusion. Cancer Chemother. Pharmacol.5, 21–26 (1980).
4. C.L. Litterst, A.F. LeRoy andA.M. Guarino,Disposition and distribution of platinum following parenteral administration of cisdichlorodiammine platinum (II) to animals, Cancer Treat. Reports63, 1485–1482 (1979).
5. F. Bertolero andC.L. Litterst,Changes in renal handling of platinum in cisplatinum-treated rats following induction of metabolic acidosis or alkalosis, Res. Comm. Chem. Path. Pharmacol.36, 273–285 (1982).